Trending archive
Every article that has appeared in Trending stays here. Search by title, journal, author or PMID, and narrow by date.
2000 articles
July 202617
Per- and polyfluoroalkyl substances and the risk of thyroid and breast cancer: Evidence from a meta-analysis and computational toxicology.
This meta-analysis evaluated the association between per- and polyfluoroalkyl substances (PFAS) exposure and the risks of thyroid and breast cancer. The analysis included literature from January 2003 to May 2025.
Dose-response relationship between exercise interventions and quality of life in older adults with cancer: A systematic review and meta-analysis.
This systematic review and meta-analysis evaluated the impact of exercise interventions on quality of life in 2557 older adults with cancer.
The Lowest PSA Level Achieved Before CRPC Predicts Abiraterone Response But Not Enzalutamide Response in Metastatic CRPC.
This multicenter randomized controlled trial investigated the impact of the lowest prostate-specific antigen (PSA) level before castration-resistant prostate cancer (CRPC) on the efficacy of abiraterone (ABI) and…
Phase I study of glofitamab in Japanese patients with relapsed or refractory B-cell non-Hodgkin lymphoma.
This Phase I study evaluated the safety, pharmacokinetics, and efficacy of glofitamab in Japanese patients with relapsed or refractory B-cell non-Hodgkin lymphoma.
Genomic and molecular landscape of early onset colorectal cancer: Emerging insights and clinical implications-A systematic review.
This systematic review analyzed the genomic and molecular characteristics of early onset colorectal cancer (EOCRC) in approximately 19,888 patients.
Ablative radiotherapy in castration-resistant prostate cancer.
This randomized phase II trial evaluated the efficacy of metastasis-directed therapy (MDT) in patients with castration-resistant prostate cancer (CRPC) and up to five metastases.
Artificial intelligence for predicting pathological complete response to neoadjuvant therapy in triple-negative breast cancer: A systematic review and meta-analysis.
This systematic review and meta-analysis evaluated the effectiveness of artificial intelligence (AI) models in predicting pathological complete response (pCR) to neoadjuvant therapy in early triple-negative breast…
Efficacy and safety of a novel oral anti-vasculogenic mimicry agent, CVM-1118, in advanced well-differentiated neuroendocrine tumors: a Phase IIa trial.
This Phase IIa trial evaluated the efficacy and safety of CVM-1118 in 43 patients with advanced well-differentiated neuroendocrine tumors (NETs) who were refractory to standard therapies.
Management considerations of ameloblastic carcinoma in soft-tissue: case report and literature review.
A 36-year-old woman with a history of mandibular ameloblastoma underwent segmental mandibulectomy and reconstruction. Three years later, she presented with a submental swelling, which was initially diagnosed as…
Diagnostic performance of artificial intelligence based on PET/CT for lymph node involvement in prostate cancer: A systematic review and meta-analysis.
This systematic review and meta-analysis evaluated the diagnostic performance of PET/CT-based artificial intelligence (AI) models for detecting lymph node involvement in prostate cancer, comparing them to physician…
Early diagnosis of capivasertib-associated severe hyperglycemia with diabetic ketosis diagnosed in routine clinical practice: a case report with review of literature.
A 61-year-old woman without known glucose intolerance developed severe hyperglycemia with diabetic ketosis within 4 days of starting capivasertib for advanced breast cancer.
Concurrent chemoradiotherapy with or without simultaneous integrated boost for unresectable stage III non-small-cell lung cancer: a randomized phase II trial with exploratory EGFR and PD-L1 analyses.
This randomized phase II trial evaluated the impact of simultaneous integrated boost (SIB) radiotherapy on progression-free survival (PFS) and overall survival (OS) in 168 patients with unresectable stage III…
Germline pathogenic PTEN variant in a patient with a Kaposiform haemangioendothelioma.
A 28-year-old female presented with Kaposiform haemangioendothelioma (KHE) and was found to have a germline pathogenic PTEN variant. Initial detection in tumor tissue was confirmed in saliva.
Neuroprotection and prevention of oxaliplatin-induced neuropathy with Huangqi Guizhi Wuwu Decoction: a 12-center randomized, double-blind trial with mechanistic validation.
This multicenter, randomized, double-blind trial evaluated the efficacy of Huangqi Guizhi Wuwu Decoction (HQGZWWD) in preventing oxaliplatin-induced peripheral neuropathy (OIPN) in 360 adults with colorectal cancer…
Liver Tumor Motion and Reconstructed Doses in a Clinical Trial of Respiratory-Gated Proton Therapy for Hepatocellular Carcinoma.
This prospective phase II clinical trial evaluated tumor motion and reconstructed delivered doses during respiratory-gated pencil beam scanning proton therapy in 16 patients with hepatocellular carcinoma.
Efficacy and Tolerability of Zenocutuzumab in Advanced NRG1 Fusion-Positive Cholangiocarcinoma: Results From the eNRGy Phase II Trial.
This single-arm, multicenter phase II trial evaluated zenocutuzumab in previously treated or standard-therapy-ineligible adults with advanced NRG1 fusion-positive cholangiocarcinoma.
Case Report: Pancreatic Paraganglioma Mimicking a Well-Differentiated Neuroendocrine Tumor: The Importance of Cytokeratin Immunohistochemistry.
A 79-year-old woman presented with an incidental lesion in the pancreatic head, initially suspected to be a well-differentiated neuroendocrine tumor.
June 20267
Sex-Specific Differences in Disease-Free, Progression-Free and Overall Survival Following Enfortumab Vedotin Therapy for Advanced or Metastatic Urothelial Cancer: A Systematic Review and Meta-analysis.
This systematic review and meta-analysis evaluated sex-specific survival outcomes in patients with advanced or metastatic urothelial cancer treated with enfortumab vedotin.
Effect of malaria parasitaemia on antibody responses to single-dose and two-dose HPV vaccination: results from the DoRIS dose-reduction immunogenicity trial in Tanzanian girls.
This randomized controlled trial evaluated the impact of malaria parasitaemia on HPV vaccine immune responses in 930 HIV-negative Tanzanian schoolgirls aged 9-14 years.
A single-arm prospective phase I trial of 68Ga-PFBC01 PET/CT for multiple myeloma B cell maturation antigen imaging.
This single-arm phase I trial evaluated the safety and diagnostic performance of 68Ga-PFBC01 PET/CT in 50 patients with multiple myeloma.
Perioperative tislelizumab for early-stage hepatocellular carcinoma: A phase II trial with integrated tumour microenvironment profiling and predictive modeling.
This phase II trial evaluated tislelizumab monotherapy as a neoadjuvant treatment for 36 patients with resectable early-stage hepatocellular carcinoma (HCC).
Hemophagocytic Lymphohistiocytosis and Fibroblast Growth Factor 23 (FGF23)-Induced Hypophosphatemia.
A patient with acute lymphoblastic leukemia developed severe, refractory hypophosphatemia characterized by renal phosphate wasting, triggered by hemophagocytic lymphohistiocytosis.
Kidney Transplantation Post-Chimeric Antigen Receptor (CAR) T-Cell Therapy in Multiple Myeloma.
A 71-year-old man with stage III multiple myeloma and end-stage kidney disease underwent ciltacabtagene autoleucel CAR T-cell therapy, achieving minimal residual disease (MRD)-negative status.
Lymphedema therapy in head & neck cancer with carotid stenosis: a systematic review and care pathway.
This systematic review aimed to develop a clinical care pathway for managing lymphedema in head and neck cancer survivors at risk for carotid atherosclerosis.
Showing the most recent matches. Add a word or a date to reach older ones.
Stay updated for free
Get the 3 most interesting publications in one specialty each week.
Weekly email. Unsubscribe anytime.
Want this personalized?
Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.
- Your specialties
- Your filters and thresholds
- Clinical Research + Case Reports, tuned separately
- Automatic weekly delivery
- Audio and text
Prefer listening? Personalized audio digests are available with Pro.